Autophagy controls mesenchymal stem cell properties and senescence during bone aging

Area of Science:

• Stem Cell Biology
• Gerontology
• Bone Biology

Background:

• Aging bone marrow-derived mesenchymal stem cells (BMMSCs) show reduced proliferation and imbalanced differentiation, contributing to age-related bone loss.
• Autophagy, a cellular degradation process, is found to be significantly reduced in aged BMMSCs.

Purpose of the Study:

• To investigate the role of autophagy in the aging of BMMSCs.
• To explore the potential of modulating autophagy for treating age-related bone loss.

Main Methods:

• In vitro studies using autophagy inhibitors (3-methyladenine) and activators (rapamycin) on young and aged BMMSCs.
• In vivo studies involving autophagy activation in aged mice.
• Analysis of reactive oxygen species and p53 levels.

Main Results:

• Inhibition of autophagy in young BMMSCs mimicked aging phenotypes (reduced osteogenesis, proliferation; enhanced adipogenesis).
• Activation of autophagy in aged BMMSCs restored their differentiation and proliferation capacity.
• Autophagy modulation affected reactive oxygen species and p53 levels.
• In vivo autophagy activation reversed bone loss in aged mice.

Conclusions:

• Autophagy plays a critical role in the aging process of BMMSCs.
• Activating autophagy can partially reverse BMMSC aging and bone loss.
• Autophagy modulation presents a potential therapeutic strategy for age-related bone diseases.